286 related articles for article (PubMed ID: 33338849)
1. Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
Nabeshima S; Yamasaki M; Matsumoto N; Takaki S; Nishi Y; Kawamoto K; Taniwaki M; Ohashi N; Hattori N
Cancer Treat Res Commun; 2021; 26():100270. PubMed ID: 33338849
[TBL] [Abstract][Full Text] [Related]
2. Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up.
McClure T; Cui W; Asadi K; John T; Testro A
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32912846
[TBL] [Abstract][Full Text] [Related]
3. A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Hirasawa Y; Yoshimura K; Matsui H; Kubota Y; Ishida H; Arai J; Sakaki M; Oguro N; Shida M; Taniguchi M; Hamada K; Ariizumi H; Ishiguro T; Ohkuma R; Sambe T; Horiike A; Imamura CK; Shiozawa E; Wada S; Tsurutani J; Iwamoto S; Uchida N; Kiuchi Y; Tate G; Kobayashi S; Tsunoda T
Medicine (Baltimore); 2021 Jun; 100(23):e25774. PubMed ID: 34114983
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab-induced sclerosing cholangitis in a lung adenocarcinoma patient with a remarkable response to chemotherapy: a case report.
Sato K; Hayashi M; Abe K; Fujita M; Takahashi A; Ohira H
Clin J Gastroenterol; 2020 Dec; 13(6):1310-1314. PubMed ID: 32643124
[TBL] [Abstract][Full Text] [Related]
5. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review.
Onoyama T; Takeda Y; Yamashita T; Hamamoto W; Sakamoto Y; Koda H; Kawata S; Matsumoto K; Isomoto H
World J Gastroenterol; 2020 Jan; 26(3):353-365. PubMed ID: 31988594
[TBL] [Abstract][Full Text] [Related]
7. Anti programmed death-ligand 1 antibody-related cholangitis without bile duct dilation or stenosis.
Azami T; Takano Y; Noda J; Yamawaki M; Yoshida E; Niiya F; Maruoka N; Ogawa T; Ichikawa W; Nagahama M
Clin J Gastroenterol; 2022 Aug; 15(4):818-821. PubMed ID: 35729450
[TBL] [Abstract][Full Text] [Related]
8. Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report.
Tanaka T; Sakai A; Tsujimae M; Yamada Y; Kobayashi T; Masuda A; Kodama Y
World J Gastroenterol; 2022 Jul; 28(28):3732-3738. PubMed ID: 36161046
[TBL] [Abstract][Full Text] [Related]
9. A case with life-threatening secondary sclerosing cholangitis caused by nivolumab.
Yoshikawa Y; Imamura M; Yamaoka K; Kosaka Y; Murakami E; Morio K; Fujino H; Nakahara T; Okamoto W; Yamauchi M; Kawaoka T; Tsuge M; Hiramatsu A; Hayes CN; Aikata H; Fujitaka K; Arihiro K; Hattori N; Chayama K
Clin J Gastroenterol; 2021 Feb; 14(1):283-287. PubMed ID: 33200345
[TBL] [Abstract][Full Text] [Related]
10. Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Yamamoto T; Mizuno K; Ito T; Yokoyama S; Yamamoto K; Imai N; Ishizu Y; Honda T; Ishikawa T; Kanamori A; Yasuda S; Toyoda H; Yokota K; Hase T; Nishio N; Maeda O; Ishii M; Sone M; Ando Y; Akiyama M; Ishigami M; Kawashima H
Invest New Drugs; 2023 Jun; 41(3):512-521. PubMed ID: 37171720
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic usefulness of precise examinations with intraductal ultrasonography, peroral cholangioscopy and laparoscopy of immunoglobulin G4-related sclerosing cholangitis.
Horiguchi S; Ikeda F; Shiraha H; Yamamoto N; Sakakihara I; Noma Y; Tsutsumi K; Kato H; Hagihara H; Yasunaka T; Nakamura S; Kobashi H; Kawamoto H; Yamamoto K
Dig Endosc; 2012 Sep; 24(5):370-3. PubMed ID: 22925292
[TBL] [Abstract][Full Text] [Related]
12. [A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy].
Nagasawa S; Miyazaki M; Morita Y; Tanaka K; Yada M; Masumoto A; Motomura K
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(10):981-990. PubMed ID: 34629349
[TBL] [Abstract][Full Text] [Related]
13. Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.
Ardizzoni A; Azevedo S; Rubio-Viqueira B; RodrÃguez-Abreu D; Alatorre-Alexander J; Smit HJM; Yu J; Syrigos K; Trunzer K; Patel H; Tolson J; Cardona A; Perez-Moreno PD; Newsom-Davis T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737339
[TBL] [Abstract][Full Text] [Related]
14. A rare case of immunotherapy-induced cholangitis and gastritis.
Fujii M; Ozato T; Mizukawa S; Nasu J; Kawai H; Fujioka SI; Yoshioka M; Shiode J; Yamamoto K
Clin J Gastroenterol; 2020 Dec; 13(6):1083-1090. PubMed ID: 32886336
[TBL] [Abstract][Full Text] [Related]
15. Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review.
Xie W; Hu N; Cao L
Front Immunol; 2021; 12():790051. PubMed ID: 34956221
[TBL] [Abstract][Full Text] [Related]
16. Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature.
Larsen EP; Bayat A; Vyberg M
Diagn Pathol; 2012 Aug; 7():100. PubMed ID: 22891962
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
Zen Y; Grammatikopoulos T; Heneghan MA; Vergani D; Mieli-Vergani G; Portmann BC
Am J Surg Pathol; 2012 Oct; 36(10):1555-61. PubMed ID: 22982898
[TBL] [Abstract][Full Text] [Related]
18. Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease.
Acikgoz O; Bayramgil A; Cavusoglu G; Sadri S
J Oncol Pharm Pract; 2021 Dec; 27(8):2066-2068. PubMed ID: 34282980
[TBL] [Abstract][Full Text] [Related]
19. Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes.
Zen Y; Chen YY; Jeng YM; Tsai HW; Yeh MM
Histopathology; 2020 Feb; 76(3):470-480. PubMed ID: 31550390
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of laparoscopy and intraductal ultrasonography in a patient with isolated immunoglobulin G4-related sclerosing cholangitis.
Ohno Y; Kumagi T; Imamura Y; Kuroda T; Koizumi M; Watanabe T; Yoshida O; Tokumoto Y; Takeshita E; Abe M; Harada K; Hiasa Y
Clin J Gastroenterol; 2018 Feb; 11(1):62-68. PubMed ID: 29094322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
